Taurine 7 pp 491-499 | Cite as

Effect of Taurine on Antioxidant Enzyme System in B16F10 Melanoma Cells

  • Jisun Yu
  • An Keun Kim
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)


There is now increasing evidence that free radicals and reactive oxygen species (ROS) are involved in a variety of pathological events. Reactive oxygen species are produced during normal cellular function and lead to lipid peroxidation, massive protein oxidation and degradation. Taurine is an abundant free amino acid in inflammatory cells, where it is thought to be cytoprotective. The aim of the present study was to examine whether taurine enhances endogenous antioxidant enzyme activity and/ or regulates ROS generation in B16F10 mouse melanoma cells. B16F10 cells were exposed to medium containing taurine for a period of 24 h. Cell viability, measured by the MTT assay, exhibited a dose-dose dependent inhibition. Taurine increased the activities of superoxide dismutase, glutathione peroxidase and CAT compared to those of the control, an effect paralleling an increase in gene expression. Taurine also reduced ROS content in a dose-dependent manner. Taken together, our results suggest that taurine decreases ROS levels by increasing the levels of the antioxidant enzymes.


Reactive Oxygen Species Antioxidant Enzyme Melanoma Cell Reactive Oxygen Species Level B16F10 Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aebi Hugo (1984) Catalase in vitro. Method Enzymol 105:93–127CrossRefGoogle Scholar
  2. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–34PubMedCrossRefGoogle Scholar
  3. Birdsall TC (1998) Therapeutic applications of taurine. Altern Med Rev 3:128–136PubMedGoogle Scholar
  4. Bouckenooghe T, Remacle C, Reusens B (2006) Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9:728–33PubMedCrossRefGoogle Scholar
  5. Chang L, Xu JX, Zhao J, Pang YZ, Tang CS, Qi YF (2004) Taurine antagonized oxidative stress injury induced by homocysteine in rat vascular smooth muscle cells. Acta Pharmacol Sin 25:341–346PubMedGoogle Scholar
  6. Fruehauf J, Meyskens F (2007) Reactive Oxygen Species:A Breath of Life or Death? Clin Cancer Res 13:789–794PubMedCrossRefGoogle Scholar
  7. Halliwell B (1991) Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91:14–22CrossRefGoogle Scholar
  8. Halliwell B (1994) Free radicals, antioxidants and human diseases: curiosity, cause or consequently? Lancet 334:721–724CrossRefGoogle Scholar
  9. Hong WK, Spron MB (1997) Recent advances in chemoprevention of cancer. Science 278:1073–1077PubMedCrossRefGoogle Scholar
  10. Inoue M, Sato EF, Nishikawa M (2003) Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 10:2495–505PubMedCrossRefGoogle Scholar
  11. Martin JP, Dailey M, Sugarman E (1987) Negative and positive assays superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys 255:329–336PubMedCrossRefGoogle Scholar
  12. Matés, JM., Pérez-Gómez, C., Núñez de Castro, I., (1999) Antioxidant enzymes and human diseases. Clin Biochem 32:595–603PubMedCrossRefGoogle Scholar
  13. Matés JM (2001) Effect of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153:83–10.CrossRefGoogle Scholar
  14. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMedGoogle Scholar
  15. Pokhrel PK, Lau-Cam CA (2000) In vitro and in vivo effects of taurine and structurally related sulfur-containing compounds against phenylhydrazine-induced oxidative damage to erythrocytes. Adv Exp Med Biol 483:503–522PubMedCrossRefGoogle Scholar
  16. Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29(1):117–26PubMedCrossRefGoogle Scholar
  17. Sener G, Ozer Sehirli A, Ipçi Y, Cetinel S, Cikler E, Gedik N, Alican I (2005) Taurine treatment protects against chronic nicotine-induced oxidative changes. Fundam Clin Pharmacol19:155–164PubMedCrossRefGoogle Scholar
  18. Slater T (1984) Free radical mechanisms in tissue injury. Biochem J 222:1–15PubMedGoogle Scholar
  19. Sporn MB, Suh N (2002) Chemoprevention:an essential approach to controlling cacner. Nat Rev Cancer 2:537–554PubMedCrossRefGoogle Scholar
  20. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR (1991) Tetrasodium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51:2515–2520PubMedGoogle Scholar
  21. Yagi K (1987) Lipid peroxidation and human diseases. Chem. Phys Lipids 45:337–351PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jisun Yu
    • 1
  • An Keun Kim
  1. 1.College PharmacySookmyung Women’s UniversitySeoulKorea

Personalised recommendations